Scholar Rock Holding (SRRK) Preferred Stock Liabilities (2017)

Scholar Rock Holding (SRRK) posted quarterly Preferred Stock Liabilities of $109.2 million for Q4 2017.

Scholar Rock Holding (SRRK) Preferred Stock Liabilities (2017) Analysis & Trends

Scholar Rock Holding's Preferred Stock Liabilities history runs 1 years deep, the most recent figure standing at $109.2 million for Q4 2017.

In Q4 2017, Preferred Stock Liabilities changed N/A year-over-year to $109.2 million; the TTM figure through Dec 2017 stood at $109.2 million (changed N/A YoY), while the FY2017 annual figure was $109.2 million, changed N/A from the prior year.
Preferred Stock Liabilities for Q4 2017 stood at $109.2 million.
The five-year high for Preferred Stock Liabilities was $109.2 million in Q4 2017, with the low at $109.2 million in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Scholar Rock Holding	6.39 Bn	6.39 Bn	-	-

Download Data

Date	Value
Dec 31, 2017	109.23 Mn